Although randomized trials are ongoing (NCT05444712 [22]) and low-risk cases such as those with DUSP22r may be considered for chemotherapy alone, consolidative transplant should still be a treatment consideration in most patients with ALK − ALCL. This evidence concerns the gene ALK and anaplastic large cell lymphoma.